Management of Gynecologic Oncology Patients with a Preoperative Deep Vein Thrombosis

By Hoffman M.S.   DeCesare S.   Fiorica J.V.   Roberts W.S.   Cavanagh D.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 76-79

Elsevier

Access to resources Recommend Favorite

Evaluation of patient chemotherapy education in a gynecology oncology center

By Smith Judith  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 577-583

Springer Publishing Company

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M.   Blessing J.A.   Wolf J.   Rocereto T.F.   Berek J.S.   Waggoner S.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

By Manetta A.   Blessing J.A.   Hurteau J.A.  

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 45-46

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of Oral Trimetrexate in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Fowler J.M.   Blessing J.A.   Burger R.A.   Malfetano J.H.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 311-314

Academic Press

Access to resources Recommend Favorite